Compare Iovance Biotherapeutics Inc. Common Stock (IOVA) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Iovance Biotherapeutics Inc. Common Stock vs Plug Power Inc — how do they compare? Iovance Biotherapeutics Inc. Common Stock trades at $13.36 (market cap $5.85B), while Plug Power Inc trades at $1.74 (market cap $2.49B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 2.3× Plug Power Inc's market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, Plug Power Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Iovance Biotherapeutics Inc. Common Stock for 0 Days and Plug Power Inc for 41 Days on average.
| IOVA | PLUG | |
|---|---|---|
Market Cap | $5.85B | $2.49B |
Volume | 14,517,176 | 47,846,349 |
Sector | Health | Industrials |
52-Week High | $14.82 | $4.14 |
52-Week Low | $1.81 | $1.73 |
Typical Hold Time | 0 Days | 41 Days |
Enterprise Value | $5.78B | $3.36B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Plug Power (PLUG) trades at $1.73, down 6.99% today, with a bearish technical signal and negative earnings momentum. The company continues to report significant losses with a -220.59% net income margin and negative cash flow, though recent electrolyzer supply agreements and international expansion provide some operational catalysts. Analyst sentiment is mixed with 44.73% buy ratings but a consensus price target of $3.13 suggesting 81% upside potential from current levels.
The stock faces substantial fundamental challenges with persistent losses and negative cash flow, but maintains analyst support due to its positioning in the growing green hydrogen market. Key risks include execution challenges in achieving profitability, high cash burn requiring continued financing, and competitive pressures in the clean energy sector. The current price near the analyst low target of $1.65 indicates limited downside protection.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
